TD Cowen Reiterates Hold Rating on Cardinal Health (CAH)

TD Cowen analyst Charles Rhyee reiterated a Hold rating and $116.00 price target on Cardinal Health (NYSE: CAH).

The analyst commented, "CAH announced a definitive agreement to acquire Integrated Oncology Network (ION) for $1.115B in cash. The acquisition reflects CAH's push to expand in the specialty space. CAH noted it expects the transaction to be accretive to adj EPS 12 months after the close. We estimate ION's service business and drug purchasing may each represent a +1-2% impact to CAH's adj EPS over the medium to long-term."

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $111.84 yesterday.

You May Also Be Interested In

• Discovery Energy Metals plans private placement of up to $1.25M
• Western Midstream Partners (WES) PT Raised to $48 at UBS
• NSA sets July 22 closing for Public Storage acquisition